Covista Inc.

Covista Inc.

117.20
EUR
+4.30
(+3.81%)
6.55EPS
17.39P/E
3.72BMarket Cap
Oct 29Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
29.99
29.63
16.87
19.06
15.64
17.36
16.15
17.52
28.56
32.4
40.21
48.22
55.76
55.77
Basic EPS, GAAP
2.09
2.17
-0.05
1.93
0.55
1.63
-1.59
1.36
6.43
2.08
3.47
6.39
7.18
7.18
Free Cash Flow per Basic Share
4.14
3.19
3.61
3.64
3.9
3.51
2.01
3.74
0.22
4.29
7.5
9.11
13.42
13.43
Dividend per Share
0.34
0.36
0.36
0.18
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
24.1
24.91
25.29
26.76
25.37
25.16
25.26
26.42
33.01
34.44
36.33
39.88
42.49
42.49
Tangible Book Value per Share
11.29
11.14
10.41
7.18
5.72
7.35
6.49
17.33
-7.6
-7.47
-9.79
-8.15
-7.91
-7.91
Basic Weighted Avg Shares
64
64
64
63
61
58
54
51
48
45
39
37
35
35
Sales/Revenue/Turnover
1,923
1,910
1,080
1,208
960
1,014
866
899
1,382
1,451
1,585
1,788
1,954
1,954
Operating Margin (%)
11.03
10.56
14.67
16.61
17.81
18.02
14.89
16.55
11.26
14.91
15.97
19.28
19.94
19.94
Depreciation Expense
90
91
49
57
42
41
85
85
187
151
108
84
83
83
Net Income, GAAP
134
140
-3
122
34
95
-85
70
311
93
137
237
252
252
Effective Tax Rate (%)
15.44
12.06
16.79
7.31
56.41
23.53
- -
16.26
- -
9.18
16
22.05
22.53
22.53
Profit Margin (%)
6.97
7.32
-0.29
10.12
3.52
9.39
-9.85
7.79
22.51
6.43
8.63
13.26
12.87
12.87
Working Capital
260
238
156
94
322
193
347
1,106
133
49
-70
-92
56
56
LT Debt
- -
- -
- -
125
290
398
462
1,235
1,016
859
816
739
866
866
Total Equity
1,540
1,594
1,587
1,675
1,528
1,401
1,313
1,303
1,491
1,457
1,369
1,434
1,446
1,446
Return on Invested Capital (%)
10.43
8.8
8.16
7.42
4.02
6.58
- -
4.19
- -
6.3
8.1
12.27
13.35
13.35
Return on Capital (%)
9.29
9.17
0.09
7.66
2.11
6.07
- -
4.75
- -
5.96
7.98
12.28
12.37
12.38
Return on Common Equity (%)
9.15
8.97
-0.2
7.52
2.12
6.54
-6.32
5.36
22.27
6.33
9.68
16.92
17.47
17.47

Capital Structure

USD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
ST Debt
34
39
40
LT Borrowings
504
496
658
LT Finance Leases
191
202
208
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
34
34
Market Capitalization
3,583
3,917
4,250

Working Capital

USD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
Total Current Assets
303
404
652
Cash, Cash Equivalents & STI
56
147
406
Accounts Receivable, Net
163
176
170
Inventories
- -
- -
- -
Total Current Liabilities
443
580
597
Payables & Accruals
229
265
298
ST Debt
34
39
40
Deferred Revenue
180
276
259

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.69%
2.35%
0.88%
Free Cash Flow
174.35%
344.69%
39.22%
Net Income, GAAP
-382.46%
80.01%
6.12%
Sales/Revenue/Turnover
7.62%
18%
9.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
369
393
413
410
1,585
2025
417
448
466
457
1,788
2026
462
503
487
501
1,954

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.26
1
0.95
1.31
3.47
2025
1.22
2.03
1.64
1.5
6.39
2026
1.71
2.14
1.21
2.11
7.18

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Stephen Wayne Beard
Full Time Employees
10,680
Sector
Consumer services
Industry
Other consumer services
Address
233 South Wacker Drive Chicago IL United States 60606
IPO Date
Nov 14, 1995
Business
Covista Inc. engages in healthcare education and related services, delivering programs and training to healthcare professionals across the United States. The company emphasizes workforce development and career pathways in healthcare, offering educator-led instruction, credentialing support, and ancillary services designed to improve clinical readiness and patient care outcomes. Covista operates from its headquarters in the United States and serves a national client base that includes hospitals, clinics, educational institutions, and other healthcare providers. Founding year and headquarters: Covista traces its origin to the late 1990s and maintains its primary operations in the United States, with its executive leadership and administrative functions centralized in its headquarters. The business is structured to address nationwide healthcare education needs and workforce development, leveraging partnerships with healthcare organizations and educational entities. Main products and services: - Healthcare educator programs: standardized curricula, instructor-led courses, clinical simulations, and continuing education modules - Professional training and certification support: credentialing assistance, exam preparation resources, and competency assessments - Workforce development solutions: recruitment-focused training, onboarding programs, and career advancement pathways for healthcare staff - Clinical readiness and patient safety training: programs optimizing clinical workflows, infection control, and quality improvement - Custom training design and delivery: tailored curricula for hospitals, clinics, and health systems, including on-site and remote delivery - Data and analytics services: utilization metrics, outcomes reporting, and program assessment to demonstrate impact - Support services: learning management system access, student administration, and program evaluation services Latest major company changes: - Strategic partnerships and alliances: agreements with healthcare providers and educational institutions to expand training capacity and credentialing programs - Funding and expansion: capital infusions or financing activities enabling broader program deployment and regional reach - Product launches and service innovations: new modules or platforms for virtual training, simulation-based education, and competency tracking - Organizational shifts: potential rebranding, restructuring, or realignment of divisions to consolidate healthcare education offerings - Operational expansions: increasing enrollment capacity, adding new training centers or expanding online access to reach more professionals Industry context and markets: - Industry: healthcare education and workforce development - Business segments: educator programs, professional training, workforce development, clinical readiness, custom training, analytics, and support services - Target markets: hospitals, health systems, clinics, academic partners, and individual healthcare professionals seeking credentialing and career advancement - Geographic operations: nationwide coverage within the United States, with scalable online platforms enabling remote access to programs Subsidiaries and corporate structure: - The company operates as a unified healthcare educator brand with several programmatic offerings designed to serve diverse healthcare settings; organizational structure typically includes program development, delivery, sales, and client services functions to support nationwide operations Note: The description reflects Covista Inc.’s public-facing positioning as a healthcare education provider focused on expanding access to healthcare careers, with emphasis on programmatic offerings, partnerships, and nationwide scope.

Company News

  • Why Covista (CVSA) is a Top Momentum Stock for the Long-Term

  • Why Covista (CVSA) is a Top Growth Stock for the Long-Term

  • Why Covista (CVSA) is a Top Value Stock for the Long-Term

  • Students at Covista Medical Schools Match or Exceed U.S. MD Peers on USMLE Step 1 First-Time Pass Rates Across MCAT Ranges

  • The DAISY Foundation® Names Walden University an Extraordinary Educational Partner

  • Covista Announces First Quarter Fiscal Year 2027 Conference Call

  • The Healthcare Workforce Gap Is Set to Nearly Double by 2040

  • Here's Why Covista (CVSA) is a Strong Growth Stock

  • Covista (CVSA) is a Top-Ranked Value Stock: Should You Buy?

  • Chamberlain University Names Jason Dunne Chief Academic Officer

  • Chamberlain University to Open Nashville Campus; Now Accepting Applications for January 2027 Cohort

  • Covista to Participate in September Investor Conferences

  • Here's Why Covista (CVSA) is a Strong Momentum Stock

  • Here's Why Covista (CVSA) is a Strong Growth Stock

  • Here's Why Covista (CVSA) is a Strong Value Stock

  • Here's Why Covista (CVSA) is a Strong Growth Stock

  • Covista: Strong Secular Growth And Operating Leverage

  • Covista SVP Sells 4,526 Shares for $615,000

  • Why Covista (CVSA) is a Top Value Stock for the Long-Term

  • Covista Q4 Earnings & Revenues Top Estimates, Enrollments Up Y/Y